Annual CFF
$21.40 M
+$18.98 M+784.66%
December 31, 2023
Summary
- As of February 6, 2025, LUNG annual cash flow from financing activities is $21.40 million, with the most recent change of +$18.98 million (+784.66%) on December 31, 2023.
- During the last 3 years, LUNG annual CFF has fallen by -$213.43 million (-90.89%).
- LUNG annual CFF is now -90.89% below its all-time high of $234.83 million, reached on December 31, 2020.
Performance
LUNG Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$459.00 K
+$481.00 K+2186.36%
September 30, 2024
Summary
- As of February 6, 2025, LUNG quarterly cash flow from financing activities is $459.00 thousand, with the most recent change of +$481.00 thousand (+2186.36%) on September 30, 2024.
- Over the past year, LUNG quarterly CFF has increased by +$442.00 thousand (+2600.00%).
- LUNG quarterly CFF is now -99.77% below its all-time high of $199.76 million, reached on December 31, 2020.
Performance
LUNG Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$1.32 M
-$112.00 K-7.83%
September 30, 2024
Summary
- As of February 6, 2025, LUNG TTM cash flow from financing activities is $1.32 million, with the most recent change of -$112.00 thousand (-7.83%) on September 30, 2024.
- Over the past year, LUNG TTM CFF has dropped by -$20.08 million (-93.84%).
- LUNG TTM CFF is now -99.44% below its all-time high of $234.83 million, reached on December 31, 2020.
Performance
LUNG TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
LUNG Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +784.7% | +2600.0% | -93.8% |
| 3 y3 years | -90.9% | +2600.0% | -93.8% |
| 5 y5 years | +76.7% | +2600.0% | -93.8% |
LUNG Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +784.7% | -97.8% | +2186.4% | -94.0% | at low |
| 5 y | 5-year | -90.9% | +784.7% | -99.8% | +2186.4% | -99.4% | +0.8% |
| alltime | all time | -90.9% | +784.7% | -99.8% | +2186.4% | -99.4% | +0.8% |
Pulmonx Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $459.00 K(-2186.4%) | $1.32 M(-7.8%) |
| Jun 2024 | - | -$22.00 K(-102.5%) | $1.43 M(-7.4%) |
| Mar 2024 | - | $864.00 K(+4982.4%) | $1.54 M(-92.8%) |
| Dec 2023 | $21.40 M(+784.7%) | $17.00 K(-97.0%) | $21.40 M(-0.2%) |
| Sep 2023 | - | $571.00 K(+520.7%) | $21.45 M(-1.5%) |
| Jun 2023 | - | $92.00 K(-99.6%) | $21.79 M(-0.2%) |
| Mar 2023 | - | $20.72 M(>+9900.0%) | $21.82 M(+802.2%) |
| Dec 2022 | $2.42 M | $67.00 K(-92.6%) | $2.42 M(-3.3%) |
| Sep 2022 | - | $906.00 K(+591.6%) | $2.50 M(-3.6%) |
| Jun 2022 | - | $131.00 K(-90.0%) | $2.60 M(-54.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.31 M(+776.7%) | $5.76 M(+29.2%) |
| Dec 2021 | $4.46 M(-98.1%) | $150.00 K(-85.0%) | $4.46 M(-97.8%) |
| Sep 2021 | - | $1.00 M(-69.6%) | $204.07 M(-0.7%) |
| Jun 2021 | - | $3.29 M(>+9900.0%) | $205.43 M(-12.0%) |
| Mar 2021 | - | $13.00 K(-100.0%) | $233.54 M(-0.6%) |
| Dec 2020 | $234.83 M(+414.8%) | $199.76 M(+8368.2%) | $234.83 M(+569.7%) |
| Sep 2020 | - | $2.36 M(-92.5%) | $35.07 M(+7.2%) |
| Jun 2020 | - | $31.40 M(+2300.5%) | $32.71 M(+2400.5%) |
| Mar 2020 | - | $1.31 M | $1.31 M |
| Dec 2019 | $45.62 M(+276.6%) | - | - |
| Dec 2018 | $12.11 M | - | - |
FAQ
- What is Pulmonx annual cash flow from financing activities?
- What is the all time high annual CFF for Pulmonx?
- What is Pulmonx annual CFF year-on-year change?
- What is Pulmonx quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Pulmonx?
- What is Pulmonx quarterly CFF year-on-year change?
- What is Pulmonx TTM cash flow from financing activities?
- What is the all time high TTM CFF for Pulmonx?
- What is Pulmonx TTM CFF year-on-year change?
What is Pulmonx annual cash flow from financing activities?
The current annual CFF of LUNG is $21.40 M
What is the all time high annual CFF for Pulmonx?
Pulmonx all-time high annual cash flow from financing activities is $234.83 M
What is Pulmonx annual CFF year-on-year change?
Over the past year, LUNG annual cash flow from financing activities has changed by +$18.98 M (+784.66%)
What is Pulmonx quarterly cash flow from financing activities?
The current quarterly CFF of LUNG is $459.00 K
What is the all time high quarterly CFF for Pulmonx?
Pulmonx all-time high quarterly cash flow from financing activities is $199.76 M
What is Pulmonx quarterly CFF year-on-year change?
Over the past year, LUNG quarterly cash flow from financing activities has changed by +$442.00 K (+2600.00%)
What is Pulmonx TTM cash flow from financing activities?
The current TTM CFF of LUNG is $1.32 M
What is the all time high TTM CFF for Pulmonx?
Pulmonx all-time high TTM cash flow from financing activities is $234.83 M
What is Pulmonx TTM CFF year-on-year change?
Over the past year, LUNG TTM cash flow from financing activities has changed by -$20.08 M (-93.84%)